Printer Friendly

Articles from Transplant News (December 15, 2000)

1-18 out of 18 article(s)
Title Author Type Words
Abgenix, SangStat receive orphan drug designation for acute GVHD treatment. Brief Article 180
Anti-CMV IgM titer predicts CMV disease after liver transplantation. Brief Article 166
Caprius announces assay development and license agreement with Novartis Pharma AG to market Certican. Brief Article 125
Cardiac wrap may be another transplant alternative for patients with heart failure. Brief Article 97
Cyclosporine plus delay of at least 80 days improve second stem cell transplants. Brief Article 232
Elements of Disclosure for Potential Living Donors. 132
Gene therapy steadies erratic heartbeat in pigs; potential treatment for human arrhythmias. Brief Article 142
Grafting fetal neuroblast cells into the brains of Huntington's disease patients improves motor-function-French study. Brief Article 311
HCFA products developed to help consumers understand health insurance options. Brief Article 205
Hepatitis virus infection appears to have little impact on survival after heart transplant. Brief Article 135
Iran to allow transplants from brain-dead people under certain conditions. Brief Article 210
Livers initially turned down for transplantation usually perform poorly. Brief Article 299
NIH halts study after finding use of ACE inhibitor or beta blocker rather than CCB may postpone kidney failure. Brief Article 423
Physician, health care provider guidelines to assure proper care of organ donors published in JAMA. Warren, Jim Brief Article 1292
Selected gene therapy for head and neck cancer may be feasible. Brief Article 137
Unlimited Medicare coverage of immunosuppressive drugs for transplant patients still considered likely. Brief Article 163
Video aimed at recruiting African American organ/tissue donors available. Brief Article 185
Wyeth-Ayerst's Rapamune received unanimous positive opinion from European Medicines Evaluation Agency. Brief Article 232

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters